Ovarian Cancer
Reports from Palacky University Medical School, Department of Oncology highlight recent research in ovarian cancer
Published in Women's Health Weekly, December 30th, 2010
2010 DEC 30 -- Fresh data on ovarian cancer are presented in the report 'Repeated chemosensitivity testing in patients with epithelial ovarian carcinoma.' According to recent research from Olomouc, Czech Republic, "Epithelial ovarian carcinoma (EOC) is a highly chemosensitive tumor, but most patients with advanced EOC initially responding to first-line chemotherapy will eventually relapse. Chemosensitivity testing may offer an opportunity for the optimal selection of chemotherapeutic agents for individual patients."
"In the present retrospective analysis we have examined the changes in chemosensitivity profiles during the course of the disease....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
A protein called cFLIP makes tumor cells in breast cancer resistant to treatments - Breast Cancer
Body fat distribution associated with a higher risk of ER-negative breast cancer - Breast Cancer
CTCs predict poor outcome from blood stem cell transplantation therapy for metastatic breast cancer - Breast Cancer
Catalan Institute of Oncology details research in breast cancer - Breast Cancer
Data from Keio University, Department of Pathology advance knowledge in breast cancer - Breast Cancer
Data from M. Aapro et al provide new insights into breast cancer - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
